Revatis S.A. • Actuality

All articles Company Human health Animal health

All the actualities

Read the articl

Grant of the European patent

May 2, 2026

Read the articl

Publication of an article on the use of Revatis autologous stem cells in the treatment of tendinopathies in horses

March 17, 2026

Read the articl

Patent related to the secretome and extracellular vesicles derived from muscle-derived MSC

March 5, 2026

Read the articl

Enrolment of the first patient in the clinical trial investigating the use of Revatis stem cells in the treatment of immune-mediated keratitis in horses

February 5, 2026

Read the articl

New patent issued in Japan

November 17, 2022

Read the articl

Regmed Europe in Paris - 3rd of June 2022

June 3, 2022

Read the articl

Veterinexpo 2022

April 2, 2022

Read the articl

Capital increase

January 27, 2022

Read the articl

Revatis is one of the Winners of the Global MIKE Award 2021!

December 3, 2021

Read the articl

Participation of Revatis in the BIO congress

June 8, 2021

Read the articl

Sending of Revatis cells to Australia

June 4, 2021

Read the articl

New IP publications in US

May 8, 2021

Read the articl

BIOEUROPE Spring

March 23, 2021

Read the articl

Osteoarthritis in horses clinical study approved!

March 3, 2021

Read the articl

Clinical studies for tendinopathies in horses

March 1, 2021